Twin Tree Management
UTHR icon

Twin Tree Management’s United Therapeutics UTHR Stock Holding History

Twin Tree Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,100
Closed -$3.46M – 1752
2025
Q4 		$3.46M Hold
7,100
– – 0.03% 646
2025
Q3 		$2.98M Buy
7,100
+5,000
+238% +$1.68M 0.01% 928
2025
Q2 		$603K Buy
+2,100
New +$628K ﹤0.01% 1423
2024
Q4 		– Sell
-6,600
Closed -$2.37M – 1924
2024
Q3 		$2.37M Buy
+6,600
New +$2.23M ﹤0.01% 1094
2024
Q1 		– Sell
-100
Closed -$22K – 1632
2023
Q4 		$22K Buy
+100
New +$23K ﹤0.01% 1306
2022
Q3 		– Sell
-15,700
Closed -$3.7M – 1723
2022
Q2 		$3.7M Sell
15,700
-116,300
-88% -$23.6M 0.01% 930
2022
Q1 		$23.7M Buy
+132,000
New +$25.1M 0.04% 413
2015
Q4 		– Sell
-3,700
Closed -$486K – 1600
2015
Q3 		$486K Sell
3,700
-3,200
-46% -$513K 0.01% 795
2015
Q2 		$1.2M Buy
+6,900
New +$1.24M 0.03% 578
2015
Q1 		– Sell
-3,800
Closed -$492K – 1322
2014
Q4 		$492K Hold
3,800
– – 0.01% 770
2014
Q3 		$489K Buy
+3,800
New +$392K 0.01% 713

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Twin Tree Management's UTHR Position: Q2 2025 in Review

Twin Tree Management sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 23 shares — an estimated $6.87K sold.

Twin Tree Management first reported a position in UTHR in Q4 2014 and held it in 24 quarters. The position peaked at $11.4M in Q1 2021. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Twin Tree Management reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 23 United Therapeutics shares in Q2 2025, an estimated $6.87K.
  • Twin Tree Management first reported a position in United Therapeutics in Q4 2014 and held it in 24 quarters.
  • Twin Tree Management's United Therapeutics position peaked at $11.4M in Q1 2021.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.